Cargando…
The Combination of MiRNA-196b, LCN2, and TIMP1 is a Potential Set of Circulating Biomarkers for Screening Individuals at Risk for Familial Pancreatic Cancer
Individuals at risk (IAR) of familial pancreatic cancer (FPC) are good candidates for screening. Unfortunately, neither reliable imaging modalities nor biomarkers are available to detect high-grade precursor lesions or early cancer. Circulating levels of candidate biomarkers LCN2, TIMP1, Glypican-1,...
Autores principales: | Bartsch, Detlef K., Gercke, Norman, Strauch, Konstantin, Wieboldt, Ronja, Matthäi, Elvira, Wagner, Vinona, Rospleszcz, Susanne, Schäfer, Agnes, Franke, Frederike S., Mintziras, Ioannis, Bauer, Christian, Grote, Tobias, Figiel, Jens, Di Fazio, Pietro, Burchert, Andreas, Reinartz, Silke, Pogge von Strandmann, Elke, Klöppel, Günter, Slater, Emily P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6210952/ https://www.ncbi.nlm.nih.gov/pubmed/30241369 http://dx.doi.org/10.3390/jcm7100295 |
Ejemplares similares
-
MicroRNA-196a and -196b as Potential Biomarkers for the Early Detection of Familial Pancreatic Cancer
por: Slater, Emily P., et al.
Publicado: (2014) -
Characteristics of familial pancreatic cancer families with additional colorectal carcinoma
por: Lehman, Bettina, et al.
Publicado: (2023) -
Mutant p53-ENTPD5 control of the calnexin/calreticulin cycle: a druggable target for inhibiting integrin-α5-driven metastasis
por: Pavlakis, Evangelos, et al.
Publicado: (2023) -
Extracellular Vesicle-Based Detection of Pancreatic Cancer
por: Verel-Yilmaz, Yesim, et al.
Publicado: (2021) -
Combinations of Low-Frequency Genetic Variants Might Predispose to Familial Pancreatic Cancer
por: Slater, Emily P., et al.
Publicado: (2021)